IQVIA Holdings has introduced IQVIA.ai, unveiling a unified agent-based artificial intelligence platform designed for life sciences organizations. The platform integrates IQVIA’s data assets
IQVIA.ai functions as a centralized system that combines automation, analytics, and decision support, enabling organizations to embed intelligence directly into operations while maintaining compliance with regulatory and data privacy requirements. The company has filed over 100 AI-related patents and deployed more than 150 intelligent agents, with 19 of the top 20 pharmaceutical firms already incorporating its AI tools into their workflows.
Bernd Haas, Senior Vice President of AI and Technology Solutions at IQVIA, noted, “IQVIA.ai reflects our longstanding commitment to translating innovation into practical, high-impact solutions for life sciences,” emphasizing its ability to combine data, expertise, and AI within a single framework.
Kimberly Powell, Vice President of Healthcare and Life Sciences at NVIDIA, added, “The sheer volume and complexity of data within the life sciences industry have outpaced traditional methods of research and manual workflow,” noting that the platform enables organizations to convert data into actionable insights and scale AI responsibly. The initial rollout will focus on high-priority use cases, with additional capabilities expected later in the year.